Table 1.
Antibiotic susceptibility pattern of growth positive organisms
| S No. | Antibiotics used | Resistant N (%) | Susceptible N (%) |
|---|---|---|---|
| 1 | Ciprofloxacin (n = 226) | 121 (53.5%) | 105 (46.5%) |
| 2 | Azithromycin (n =226) | 106 (46.9%) | 120 (53.1%) |
| 3 | Cotrimoxazole (n =226) | 109 (48.2%) | 117 (51.8%) |
| 4 | Amoxycillin (n =226) | 108 (47.8%) | 118 (52.2%) |
| 5 | Amikacin (n =226) | 88 (38.9%) | 138 (61.1%) |
| 6 | Cefoxitin (n =226) | 151 (66.8%) | 75 (33.2%) |
| 7 | Ceftazidime (n =226) | 132 (58.4%) | 94 (33.6%) |
| 8 | Cefepime (n =226) | 117 (51.8%) | 109 (48.2%) |
| 9 | Meropenem (n =226) | 70 (31.0%) | 156 (69.0%) |
| 10 | Imipenem (n =226) | 75 (33.2%) | 151 (66.8%) |
| 11 | Ertapenem (n =145) | 51 (35.17%) | 94 (64.83%) |
| 12 | Piperacillin/Tazobactam (n =226) | 98 (43.40%) | 128 (56.60%) |
| 13 | Aztreonam (n =226) | 108 (47.8%) | 118 (52.2%) |
| 14 | Nitrofurantoin (n =119) | 26 (21.85%) | 93 (78.15%) |
| 15 | Colistin (n =41) | 12 (29.27%) | 29 (70.63%) |
| 16 | Polymyxin B (n =41) | 8 (19.51%) | 33 (80.49%) |